UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Adherence to thiopurine treatment in out‐patients with Crohn’s disease

Alimentary pharmacology & therapeutics, 2007-07, Vol.26 (2), p.217-225

2007

Volltextzugriff (PDF)

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon γ antibody, in patients with moderate to severe Crohn’s disease

Gut, 2006-08, Vol.55 (8), p.1138-1144

2006

Volltextzugriff (PDF)

ABCB1 Single‐Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis

Clinical pharmacology and therapeutics, 2011-03, Vol.89 (3), p.422-428

2011

Volltextzugriff (PDF)

Pretreatment determination of TPMT - state of the art in clinical practice

European journal of clinical pharmacology, 2009-03, Vol.65 (3), p.219-221

2009

Volltextzugriff (PDF)

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

Gut, 2010-06, Vol.59 (6), p.752-759

2010

Volltextzugriff (PDF)

A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon

American journal of human genetics, 2006-09, Vol.79 (3), p.439-448

2006

Volltextzugriff (PDF)

6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party

Digestion, 2006-01, Vol.73 (1), p.25-31

2006

Volltextzugriff (PDF)

915 SURVEILLANCE OF THIOPURINE INDUCED NODULAR REGENERATIVE HYPERPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BY TRANSIENT ELASTOGRAPHY (FIBROSCAN) OF THE LIVER

Journal of hepatology, 2008, Vol.48, p.S343-S343

2008

Volltextzugriff (PDF)

Thiopurine treatment in inflammatory bowel disease : Clinical pharmacology and implication of pharmacogenetically guided dosing

Clinical pharmacokinetics, 2007-01, Vol.46 (3), p.187-208

2007

Volltextzugriff (PDF)

A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine

Journal of hepatology, 2005-08, Vol.43 (2), p.303-309

2005

Volltextzugriff (PDF)

Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels

Inflammatory bowel diseases, 2013-03, Vol.19 (3), p.590-598

2013

Volltextzugriff (PDF)

Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque

Blood, 2002-04, Vol.99 (8), p.2794-2800

2002

Volltextzugriff (PDF)

ABCB1 Single-Nucleotide Polymorphisms DetermineTacrolimus Response in Patients With Ulcerative Colitis

Clinical pharmacology and therapeutics, 2011, Vol.89 (3), p.422-428

2011

Volltextzugriff (PDF)

Anti- Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment

The American journal of gastroenterology, 2003-10, Vol.98 (10), p.2226-2231

2003

Volltextzugriff (PDF)

Anti-Saccharomyces Cerevisiae Antibody and 5-aminosalicylic Acid Treatment: Response

The American journal of gastroenterology, 2004-05, Vol.99 (5), p.956-956

2004

Volltextzugriff (PDF)

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis

Scandinavian journal of gastroenterology, 2005-10, Vol.40 (10), p.1205-1213

2005

Volltextzugriff (PDF)

Re: Celiac sprue: another autoimmune syndrome associated with hepatitis C

The American journal of gastroenterology, 2001-08, Vol.96 (8), p.2522-2523

2001

Volltextzugriff (PDF)

P124 - Efficacy and toxicity of tacrolimus in steroid resistant ulcerative colitis cannot be predicted by genetic polymorphisms of the CYP3 A4, CYP3 A5, ABCB1 and NR1I2 genes

Journal of Crohn's and colitis, 2009-02, Vol.3 (1), p.S60-S60

2009

Volltextzugriff (PDF)

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon antibody, in patients with moderate to severe Crohn's disease

Gut, 2006-08, Vol.55 (8), p.1138-1144

Reinisch, W

2006

Volltextzugriff (PDF)

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon g antibody, in patients with moderate to severe Crohn's disease

Gut, 2006-08, Vol.55 (8), p.1138-1144

2006

Volltextzugriff (PDF)

Clinical pharmacokinetics and use of infliximab

Clinical pharmacokinetics, 2007-01, Vol.46 (8), p.645-660

2007

Volltextzugriff (PDF)

Intestinal absorption, metabolism, and excretion of (–)-epicatechin in healthy humans assessed by using an intestinal perfusion technique

The American journal of clinical nutrition, 2013-10, Vol.98 (4), p.924-933

2013

Volltextzugriff (PDF)

Gastrointestinal absorption and metabolism of hesperetin‐7‐O‐rutinoside and hesperetin‐7‐O‐glucoside in healthy humans

Molecular nutrition & food research, 2015-09, Vol.59 (9), p.1651-1662

2015

Volltextzugriff (PDF)

Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease

PloS one, 2009-02, Vol.4 (2), p.e4496-e4496

2009

Volltextzugriff (PDF)

Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease

Digestive diseases and sciences, 2015-05, Vol.60 (5), p.1414-1423

2015

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(44)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Science & Technology
(25)
Life Sciences & Biomedicine
(24)
Female
(20)
Adult
(18)
Male
(17)
Gastroenterology & Hepatology
(15)
Middle Aged
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(12)
Treatment Outcome
(12)
Aged
(9)
Gastroenterology. Liver. Pancreas. Abdomen
(9)
Other Diseases. Semiology
(9)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(9)
Crohn Disease - Drug Therapy
(8)
Gastroenterology
(8)
Adolescent
(7)
Inflammatory Bowel Disease
(7)
Pharmacology. Drug Treatments
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adherence to thiopurine treatment in out‐patients with Crohn’s disease

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon γ antibody, in patients with moderate to severe Crohn’s disease

ABCB1 Single‐Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis

Pretreatment determination of TPMT - state of the art in clinical practice

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon

6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party

915 SURVEILLANCE OF THIOPURINE INDUCED NODULAR REGENERATIVE HYPERPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BY TRANSIENT ELASTOGRAPHY (FIBROSCAN) OF THE LIVER

Thiopurine treatment in inflammatory bowel disease : Clinical pharmacology and implication of pharmacogenetically guided dosing

A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine

Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels

Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque

ABCB1 Single-Nucleotide Polymorphisms DetermineTacrolimus Response in Patients With Ulcerative Colitis

Anti- Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment

Anti-Saccharomyces Cerevisiae Antibody and 5-aminosalicylic Acid Treatment: Response

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis

Re: Celiac sprue: another autoimmune syndrome associated with hepatitis C

P124 - Efficacy and toxicity of tacrolimus in steroid resistant ulcerative colitis cannot be predicted by genetic polymorphisms of the CYP3 A4, CYP3 A5, ABCB1 and NR1I2 genes

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon antibody, in patients with moderate to severe Crohn's disease

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon g antibody, in patients with moderate to severe Crohn's disease

Clinical pharmacokinetics and use of infliximab

Intestinal absorption, metabolism, and excretion of (–)-epicatechin in healthy humans assessed by using an intestinal perfusion technique

Gastrointestinal absorption and metabolism of hesperetin‐7‐O‐rutinoside and hesperetin‐7‐O‐glucoside in healthy humans

Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease

Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease

Suchergebnisse filtern